Latest News for: atossa

Edit

Statement of Changes in Beneficial Ownership (Form 4) (Atossa Therapeutics Inc)

Public Technologies 28 Mar 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... 0.5 ... 2 ... ATOSSA THERAPEUTICS, INC ... C/O ATOSSA THERAPEUTICS, INC.,, 10202 5TH AVE NE, SUITE 200 3 ... C/O ATOSSA THERAPEUTICS, INC., ... Atossa Therapeutics Inc.
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Atossa Therapeutics Inc)

Public Technologies 26 Mar 2025
ATOSSA THERAPEUTICS, INC ... Atossa Therapeutics, Inc ... Atossa Therapeutics, Inc ... Amended and Restated Certificate of Incorporation of Atossa Therapeutics, Inc ... Amended and Restated Bylaws of Atossa Therapeutics, Inc ... Atossa Therapeutics, Inc.
Edit

Proxy Statement (Form DEF 14A) (Atossa Therapeutics Inc)

Public Technologies 26 Mar 2025
ATOSSA THERAPEUTICS, INC ... This Proxy Statement is furnished in connection with the solicitation of proxies by the Board of Directors (the "Board") of Atossa Therapeutics, Inc ... RESOLVED, that the stockholders of Atossa Therapeutics, Inc.
Edit

Atossa Therapeutics Announces Full Year 2024 Financial Results and Provides�Corporate Update

Nasdaq Globe Newswire 25 Mar 2025
Ended 2024 with $71.1 million of cash and cash equivalents and no debt ... .
Edit

Atossa Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

Hastings Tribune 25 Mar 2025
Ended 2024 with $71.1 million of cash and cash equivalents and no debt ... .
Edit

Atossa Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update (Form 8-K) (Atossa Therapeutics Inc)

Public Technologies 25 Mar 2025
Atossa Therapeutics Announces Full Year 2024 Financial Results and Provides ... SEATTLE, March 25, 2025 -- Atossa Therapeutics, Inc ... Atossa plans to advance its lead program, (Z)-endoxifen, to target metastatic breast cancer ... About Atossa Therapeutics.
Edit

Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K) (Atossa Therapeutics Inc)

Public Technologies 25 Mar 2025
). MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Overview ... This discussion contains forward-looking statements, which are based on assumptions about the future of our business ... GAAP) ... $ ... $ ... $ ... Atossa Therapeutics Inc.
Edit

Americans Are Buying an Escape Plan

The Atlantic 22 Mar 2025
Even as Donald Trump advertises his hard-line approach to border crossers, he is actively soliciting one particular group of immigrants. rich ones. In February, Trump proposed that America start offering a U.S. “gold card” for $5 million ... The U.S ... U.S.
Edit

Atossa Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Nasdaq Globe Newswire 20 Mar 2025
Conference Call and Webcast Scheduled for Tuesday, March 25, 2025, at 8.30 a.m. Eastern Time. Conference Call and Webcast Scheduled for Tuesday, March 25, 2025, at 8.30 a.m. Eastern Time ... .
  • 1

Article Search

tools
×
×
×
×